Healthcare & Life Sciences

Janux Therapeutics

alive

About

Janux Therapeutics is a clinical-stage biotechnology company developing tumor-activated immunotherapies designed to generate tumor-specific immune responses for cancer treatment with reduced toxicity.

Explore Janux Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.